Junguo Chen

Junguo Chen

Auto-generated profile, based on publicly available information

Junguo Chen

Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2025 in Cancer Research
Verified
Journal Article
Open access
YLYanyun Lin
Yanyun Lin
YZYanhong Zhang
Yanhong Zhang
THtianze huang
tianze huang
JCJunguo Chen
Junguo Chen
GLGuanman Li
Guanman Li
PLPing Lan
Ping Lan
Metabolic reprogramming is a hallmark of cancer. Rewiring of amino acid metabolic processes provides the basis for amino acid deprivation therapies. In this study, we found that arginine biosynthesis is limited in colorectal cancer because of the deficiency of ornithine transcarbamylase. Accordingly, colorectal cancer cells met the demand for arginine by increasing external uptake. The addiction to environmental arginine resulted in the susceptibility of colorectal cancer to arginine deprivation, which dramatically decreased proliferation in colorectal cancer cells and promoted these cells to enter a reversible quiescence state. Arginine deprivation induced quiescence by activating the AMPK–p53–p21 pathway. RNA sequencing data indicated that colorectal cancer cells may be vulnerable to ferroptosis during arginine deprivation and the combination of ferroptosis inducers and arginine deprivation strongly impeded tumor growth in vivo. These findings suggest that dietary modification combined with ferroptosis induction could be a potential therapeutic strategy for colorectal cancer. Significance: Colorectal cancer dependency on arginine uptake creates a metabolic vulnerability to arginine deficiency that causes cell cycle arrest and ferroptosis sensitivity, highlighting arginine deprivation plus ferroptosis induction as a promising treatment.


17 June 2026
Verified
Other
Open access
YLYanyun Lin
Yanyun Lin
YZYanhong Zhang
Yanhong Zhang
THtianze huang
tianze huang
JCJunguo Chen
Junguo Chen
GLGuanman Li
Guanman Li
PLPing Lan
Ping Lan
Supplementary Table from Arginine Deprivation Induces Quiescence and Confers Vulnerability to Ferroptosis in Colorectal Cancer


2 May 2025
Verified
Other
Open access
YLYanyun Lin
Yanyun Lin
YZYanhong Zhang
Yanhong Zhang
THtianze huang
tianze huang
JCJunguo Chen
Junguo Chen
GLGuanman Li
Guanman Li
PLPing Lan
Ping Lan
Supplementary Table from Arginine Deprivation Induces Quiescence and Confers Vulnerability to Ferroptosis in Colorectal Cancer

2 May 2025
Verified
Other
Open access
YLYanyun Lin
Yanyun Lin
YZYanhong Zhang
Yanhong Zhang
THtianze huang
tianze huang
JCJunguo Chen
Junguo Chen
GLGuanman Li
Guanman Li
PLPing Lan
Ping Lan
Metabolic reprogramming is a hallmark of cancer. Rewiring of amino acid metabolic processes provides the basis for amino acid deprivation therapies. In this study, we found that arginine biosynthesis is limited in colorectal cancer because of the deficiency of ornithine transcarbamylase. Accordingly, colorectal cancer cells met the demand for arginine by increasing external uptake. The addiction to environmental arginine resulted in the susceptibility of colorectal cancer to arginine deprivation, which dramatically decreased proliferation in colorectal cancer cells and promoted these cells to enter a reversible quiescence state. Arginine deprivation induced quiescence by activating the AMPK–p53–p21 pathway. RNA sequencing data indicated that colorectal cancer cells may be vulnerable to ferroptosis during arginine deprivation and the combination of ferroptosis inducers and arginine deprivation strongly impeded tumor growth in vivo. These findings suggest that dietary modification combined with ferroptosis induction could be a potential therapeutic strategy for colorectal cancer.Significance: Colorectal cancer dependency on arginine uptake creates a metabolic vulnerability to arginine deficiency that causes cell cycle arrest and ferroptosis sensitivity, highlighting arginine deprivation plus ferroptosis induction as a promising treatment.